Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Proteins & Antibodies

Xentria and Meitheal Collaborate on Breakthrough Lung Disease Treatment

Xentria and Meitheal partner to develop a breakthrough drug for pulmonary sarcoidosis, aiming to improve patient outcomes.
Read More
Proteins & Antibodies

Revolutionising Antibody Engineering: The Groundbreaking Work of Sir Gregory Winter

We take a look at the work of Sir Gregory Winter, and how it has changed the landscape of therapeutic antibody production.
Read More
Proteins & Antibodies

Unravelling the Link Between Type 2 Diabetes and Proteins

In honour of this week marking Type 2 Diabetes Prevention Week, we take a look at the intricate link between the disease and proteins.
Read More
Proteins & Antibodies

Sony and Astellas Team Up to Create Breakthrough ADC Oncology Platform

Sony and Astellas join forces to develop an ADC platform that leverages Sony's Kiravia Backbone for enhanced drug delivery and stability.
Read More
Proteins & Antibodies

App Note: CAR-T: A Promising Cell Therapy for Cancer Treatment

This application note by Sino Biological explores the key steps involved in CAR-T production to provide insights into the challenges that may impede successful CAR-T therapy.
Read More
Proteins & Antibodies

Tiny but Mighty Molecular Syringe Developed Using AI

An AI-modified molecular “syringe” harnessed from bacteria could revolutionise protein delivery for gene and cancer therapies.
Read More
Proteins & Antibodies

Absolute Biotech: Cancer Research Reagents

Read More
Proteins & Antibodies

Absolute Biotech: Recombinant Antibody Services

Read More
Proteins & Antibodies

Interview with Andrew Brown, Head of Process Development Sciences at Lonza

Andrew Brown, Head of Process Development Sciences at Lonza, talks about Lonza's approach to process development.
Read More
Proteins & Antibodies

How AI is Changing the Game for Protein Design

Researchers at the University of Washington have succeeded in using machine learning to synthesise artificial enzymes which are actually functional in cells.
Read More
Proteins & Antibodies

Computational Tools and AI/ML for Antibody Engineering

Opinion leaders from Merck and AbbVie discuss how antibody-based molecular engineering is developing with new AI/ML technologies.
Read More
Proteins & Antibodies

POLIVY vs ODAC: Can the Cancer Drug Score Another Indication?

The Oncologic Drugs Advisory Committee are preparing to weigh in on whether the FDA should grant another indication for Roche’s POLIVY.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics